Cargando…

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers

BACKGROUND: Immunotherapy is effective only in limited patients. It is urgent to discover a novel biomarker to predict immune cells infiltration status and immunotherapy response of different cancers. CLSPN has been reported to play a pivotal role in various biological processes. However, a comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yihong, Wen, Haicheng, Li, Yin, Han, Ying, Tan, Jun, Guo, Cao, Cai, Changjing, Liu, Ping, Peng, Yinghui, Liu, Yihan, Wang, Xinwen, Zeng, Shan, Feng, Ziyang, Shen, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239117/ https://www.ncbi.nlm.nih.gov/pubmed/37268895 http://dx.doi.org/10.1186/s12575-023-00201-6

Ejemplares similares

Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer
por: Azenha, Diana, et al.
Publicado: (2020)

A Multi-Omics Analysis of NASH-Related Prognostic Biomarkers Associated with Drug Sensitivity and Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma
por: Huang, Qiaoqiao, et al.
Publicado: (2022)

Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker
por: Feng, Ziyang, et al.
Publicado: (2022)

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model
por: Cai, Changjing, et al.
Publicado: (2022)

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer
por: Qin, Yiming, et al.
Publicado: (2023)

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines
por: Cai, Changjing, et al.
Publicado: (2021)

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy
por: Cai, Changjing, et al.
Publicado: (2022)

The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis
por: Yang, Bing, et al.
Publicado: (2021)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling
por: Han, Ying, et al.
Publicado: (2020)

M6A “Writer” Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer
por: Cai, Changjing, et al.
Publicado: (2021)

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
por: Gao, Yan, et al.
Publicado: (2022)

AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma
por: Feng, Ziyang, et al.
Publicado: (2022)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients
por: Shen, Edward, et al.
Publicado: (2021)

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner
por: Han, Ying, et al.
Publicado: (2022)

Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma
por: Yan, Zijun, et al.
Publicado: (2022)

Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
por: Shi, Yuxin, et al.
Publicado: (2023)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma
por: Shi, Deyao, et al.
Publicado: (2022)

Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis
por: Zhou, Jing, et al.
Publicado: (2022)

Spatial multi-omics analyses of the tumor immune microenvironment
por: Hsieh, Wan-Chen, et al.
Publicado: (2022)

Integrative multi-omics reveals the metabolic and functional diversity of microbiomes in the gut microenvironment
por: Qiu, Shi, et al.
Publicado: (2023)

Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality
por: Cai, Changjing, et al.
Publicado: (2021)

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential
por: Cao, Feng, et al.
Publicado: (2023)

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
por: Tao, Yuting, et al.
Publicado: (2022)

Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis
por: Shen, Jiacheng, et al.
Publicado: (2021)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022)

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
por: Jiang, Yafei, et al.
Publicado: (2022)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Multi-Omics Integration Reveals the Crucial Role of Fusobacterium in the Inflammatory Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Qiao, Han, et al.
Publicado: (2022)

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma
por: Chang, Kun, et al.
Publicado: (2022)

FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer
por: Chen, Yihong, et al.
Publicado: (2020)

Multi-Omics Analysis of GNL3L Expression, Prognosis, and Immune Value in Pan-Cancer
por: Liu, Pei, et al.
Publicado: (2022)

BGFD: an integrated multi-omics database of barley gene families
por: Li, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_onc2iinr2df49473aieave2fca